This session delves deeper into the interconnected nature of cardiorenal metabolic (CRM) medicine and its management in primary care with a focus on heart failure and chronic kidney disease (CKD). It describes how to identify and manage patients with heart failure, and introduces information around the use of SGLT2 inhibitors (SGLT2i) in these patients. This module complements the RCGP Podcast on CRM: heart failure and CKD.
An educational grant was received by Boehringer Ingelheim Ltd for the production of this Podcast. Editorial and content decisions were made solely by the RCGP.
Time to complete this course: 30 minutes
Date of publication: 15 January 2022
Remove from search results: No
Podcast icon: No
Course index: Show
Section titles: Hide